FDA Inspection 1044232 — Piramal Pharma Solutions Inc.

Piramal Pharma Solutions Inc. — FEI 3006419237

The FDA completed an inspection of Piramal Pharma Solutions Inc. on March 14, 2018 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, KY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
126321 CFR 211.68(b)Computer control of master formula records
143521 CFR 211.42(c)(10)(v)Cleaning System
185121 CFR 211.84(e)Rejecting When Specifications Not Met
189021 CFR 211.165(e)Test methods
240221 CFR 211.194(a)(5)Testing Calculations